This inventor holds 2 USPTO granted patents. Top assignees: Shanghai Institute of Pharmaceutical Industry, Shanghai Zhongze Therapeutics, Co. Ltd.. Active years: 2025-2026.
Company Filing History:
2 out of 42 
2 out of 2 Years Active: 2025-2026
Title: Qiang Pu: Innovator in Pharmaceutical Compounds
Introduction
Qiang Pu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in the treatment of mental health disorders. His work exemplifies the intersection of innovation and healthcare.
Latest Patents
Qiang Pu holds a patent for a pyridinyl morpholine compound, which includes a preparation method and its applications. The invention details a pyridinyl morpholine compound represented by a specific formula, along with its pharmaceutically acceptable salts and hydrates. This compound serves as an antagonist for one or more of D, Dor 5-HT, and is intended for use in developing drugs to treat schizophrenia. He has 1 patent to his name.
Career Highlights
Throughout his career, Qiang Pu has worked with prominent organizations in the pharmaceutical industry. He has been associated with Shanghai Zhongze Therapeutics Co., Ltd. and the Shanghai Institute of Pharmaceutical Industry. His experience in these institutions has allowed him to contribute to significant advancements in drug development.
Collaborations
Qiang Pu has collaborated with several professionals in his field, including Junwei Xu and Ruixiang Yuan. These partnerships have facilitated the exchange of ideas and expertise, further enhancing his contributions to pharmaceutical innovations.
Conclusion
Qiang Pu's work in developing pharmaceutical compounds showcases his dedication to improving mental health treatment options. His innovative approach and collaborations with industry professionals highlight the importance of teamwork in advancing healthcare solutions.